Topics
Diffuse midline glioma | Treatment | Targeted therapy | EGFR inhibitors
Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy > EGFR inhibitors
Habibi MA, Rashidi F, Gharedaghi H, Fathi Tavani S, Farzalizadeh
H, Shahir Eftekhar M, Bahri A, Mohammadzadeh I, Hajikarimloo B.
Are EGFR monoclonal
antibodies associated with clinical
benefits in patients with glioma: a
systematic review, meta-analysis, and
specific analysis on glioblastoma and
diffuse intrinsic pontine glioma.
Neurosurg
Rev. 2025 Feb 8;48(1):226. doi:
10.1007/s10143-025-03335-1. PMID:
39920453. Review; Meta-analysis˰
ˍ